• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Lab Anal . Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

tetano

Editor, Senior Moderator
J Clin Lab Anal


. 2020 Oct 19;e23618.
doi: 10.1002/jcla.23618. Online ahead of print.
Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis


Linlin Cheng[SUP] 1 [/SUP], Haolong Li[SUP] 1 [/SUP], Liubing Li[SUP] 1 [/SUP], Chenxi Liu[SUP] 1 [/SUP], Songxin Yan[SUP] 1 [/SUP], Haizhen Chen[SUP] 1 2 [/SUP], Yongzhe Li[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: The coronavirus disease 2019 (COVID-19) has rapidly developed into a pandemic. Increased levels of ferritin due to cytokine storm and secondary hemophagocytic lymphohistiocytosis were found in severe COVID-19 patients. Therefore, the aim of this study was to determine the role of ferritin in COVID-19.
Methods: Studies investigating ferritin in COVID-19 were collected from PubMed, EMBASE, CNKI, SinoMed, and WANFANG. A meta-analysis was performed to compare the ferritin level between different patient groups: non-survivors versus survivors; more severe versus less severe; with comorbidity versus without comorbidity; ICU versus non-ICU; with mechanical ventilation versus without mechanical ventilation.
Results: A total of 52 records involving 10 614 COVID-19-confirmed patients between December 25, 2019, and June 1, 2020, were included in this meta-analysis, and 18 studies were included in the qualitative synthesis. The ferritin level was significantly increased in severe patients compared with the level in non-severe patients [WMD 397.77 (95% CI 306.51-489.02), P < .001]. Non-survivors had a significantly higher ferritin level compared with the one in survivors [WMD 677.17 (95% CI 391.01-963.33), P < .001]. Patients with one or more comorbidities including diabetes, thrombotic complication, and cancer had significantly higher levels of ferritin than those without (P < .01). Severe acute liver injury was significantly associated with high levels of ferritin, and its level was associated with intensive supportive care, including ICU transfer and mechanical ventilation.
Conclusions: Ferritin was associated with poor prognosis and could predict the worsening of COVID-19 patients.

Keywords: COVID-19; comorbidity; diagnosis; ferritin; mortality; severity.
 
Back
Top Bottom